First-in-human study evaluating a novel long-acting injectable antiretroviral therapy provides promising early results on its ...
The Christian Post on MSN1d
Evangelical mission doctor says ‘many will die’ if PEPFAR dismantled; Amy Grant, country artists speak outAn Evangelical mission doctor has warned that millions of lives are at stake surrounding the potential dismantling of the U S ...
The future of HIV care requires balancing scientific advancement with practical implementation. Long-acting antiretroviral ...
Kenyans living with HIV/AIDs have been told to take their antiretroviral (ARVs) pills daily without fear of running out. In a ...
Verywell Health on MSN3d
HIV vs. AIDS: How They Differ and Why Early Treatment MattersPeople with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...
Weight trajectories differed significantly among patients with HIV during the first year of ART, with no associations observed between weight gain and type of ART regimen.
Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development ...
The Citizen on MSN1d
First HIV cure clinical trial in Africa shows promise in womenA groundbreaking HIV clinical trial in Africa has demonstrated that some women can control the virus without antiretroviral therapy for extended periods after receiving a combination of treatments, ...
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...
Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million ...
News-Medical.Net on MSN13d
Dementia risk higher among adults with HIV in MalawiAdults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback